275 related articles for article (PubMed ID: 31447578)
1. A personalized approach to acute myeloid leukemia therapy: current options.
Illangeswaran RSS; Das S; Paul DZ; Mathews V; Balasubramanian P
Pharmgenomics Pers Med; 2019; 12():167-179. PubMed ID: 31447578
[TBL] [Abstract][Full Text] [Related]
2. Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice.
DeStefano CB; Hourigan CS
Ther Adv Hematol; 2018 May; 9(5):109-121. PubMed ID: 29713444
[TBL] [Abstract][Full Text] [Related]
3. The Time Has Come for Targeted Therapies for AML: Lights and Shadows.
Fiorentini A; Capelli D; Saraceni F; Menotti D; Poloni A; Olivieri A
Oncol Ther; 2020 Jun; 8(1):13-32. PubMed ID: 32700072
[TBL] [Abstract][Full Text] [Related]
4. New drugs creating new challenges in acute myeloid leukemia.
Tiong IS; Wei AH
Genes Chromosomes Cancer; 2019 Dec; 58(12):903-914. PubMed ID: 30861214
[TBL] [Abstract][Full Text] [Related]
5. Recently approved therapies in acute myeloid leukemia: A complex treatment landscape.
Talati C; Sweet K
Leuk Res; 2018 Oct; 73():58-66. PubMed ID: 30223250
[TBL] [Abstract][Full Text] [Related]
6. New Treatment Options for Acute Myeloid Leukemia in 2019.
Cerrano M; Itzykson R
Curr Oncol Rep; 2019 Feb; 21(2):16. PubMed ID: 30715623
[TBL] [Abstract][Full Text] [Related]
7. [Incorporation of novel agents into the treatment for acute myeloid leukemia].
Yamauchi T
Rinsho Ketsueki; 2018; 59(10):1988-1996. PubMed ID: 30305501
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia transformed to a targetable disease.
Saleh K; Khalifeh-Saleh N; Kourie HR
Future Oncol; 2020 May; 16(14):961-972. PubMed ID: 32297538
[TBL] [Abstract][Full Text] [Related]
9. Novel Agents for Acute Myeloid Leukemia.
Luppi M; Fabbiano F; Visani G; Martinelli G; Venditti A
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30423907
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia.
Song MK; Park BB; Uhm JE
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071627
[TBL] [Abstract][Full Text] [Related]
11. Incorporating newer agents in the treatment of acute myeloid leukemia.
Raj RV; Abedin SM; Atallah E
Leuk Res; 2018 Nov; 74():113-120. PubMed ID: 30401522
[TBL] [Abstract][Full Text] [Related]
12. Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?
Bewersdorf JP; Stahl M; Zeidan AM
Leuk Lymphoma; 2019 Jun; 60(6):1354-1369. PubMed ID: 30652518
[TBL] [Abstract][Full Text] [Related]
13. New and emerging therapies for acute myeloid leukaemia.
Davis JR; Benjamin DJ; Jonas BA
J Investig Med; 2018 Dec; 66(8):1088-1095. PubMed ID: 30127098
[TBL] [Abstract][Full Text] [Related]
14. New Food and Drug Administration-Approved and Emerging Novel Treatment Options for Acute Myeloid Leukemia.
Click ZR; Seddon AN; Bae YR; Fisher JD; Ogunniyi A
Pharmacotherapy; 2018 Nov; 38(11):1143-1154. PubMed ID: 30220082
[TBL] [Abstract][Full Text] [Related]
15. The role of targeted therapy in the management of patients with AML.
Perl AE
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):54-65. PubMed ID: 29222237
[TBL] [Abstract][Full Text] [Related]
16. The role of targeted therapy in the management of patients with AML.
Perl AE
Blood Adv; 2017 Nov; 1(24):2281-2294. PubMed ID: 29296877
[TBL] [Abstract][Full Text] [Related]
17. Will new agents impact survival in AML?
Rowe JM
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101094. PubMed ID: 31779986
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of the molecular landscape of acute myeloid leukemia.
Kayser S; Levis MJ
Haematologica; 2023 Feb; 108(2):308-320. PubMed ID: 36722402
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the benefits of available targeted therapies in acute myeloid leukaemia.
Kantarjian H; Short NJ; DiNardo C; Stein EM; Daver N; Perl AE; Wang ES; Wei A; Tallman M
Lancet Haematol; 2021 Dec; 8(12):e922-e933. PubMed ID: 34687602
[TBL] [Abstract][Full Text] [Related]
20. Progress and predictions: AML in 2018.
Rowe JM
Best Pract Res Clin Haematol; 2018 Dec; 31(4):337-340. PubMed ID: 30466743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
